Literature DB >> 19524115

Comparison of Abeta levels in the brain of familial and sporadic Alzheimer's disease.

E Hellström-Lindahl1, M Viitanen, A Marutle.   

Abstract

Mutations in presenilin (PS) and amyloid precursor protein (APP) genes are a predominant cause for early-onset familial Alzheimer disease (AD). Although these mutations are rare, they have in the past decades advanced our understanding of the underlying molecular mechanisms of AD. In the present study, Abeta levels were measured in cortical regions of APPsw and PS1 (M146V) mutation carriers, sporadic AD (SAD) and age-matched non-demented individuals. We found similar levels of soluble Abeta42, insoluble and soluble Abeta40 in both APPsw mutation carriers and SAD. However, lower levels of insoluble Abeta42 were detected in the frontal and temporal cortex of APPsw brain. In PS1 brain, insoluble Abeta40 and Abeta42 levels were significantly lower in all four cortical regions compared with SAD, whilst levels of Abeta40 were lower in frontal and occipital cortex compared with APPsw brain. The insoluble Abeta42/40 ratio was similar in SAD and APPsw but significantly higher in PS1 mutation carriers. Our results indicate that the pattern of Abeta deposition in PS1 mutation carriers differs from that in both APPsw and SAD, whereas the pattern in APPsw mutation carriers is more similar to that in SAD.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19524115      PMCID: PMC2919843          DOI: 10.1016/j.neuint.2009.03.007

Source DB:  PubMed          Journal:  Neurochem Int        ISSN: 0197-0186            Impact factor:   3.921


  55 in total

Review 1.  Alzheimer's disease: molecular understanding predicts amyloid-based therapeutics.

Authors:  Dennis J Selkoe; Dale Schenk
Journal:  Annu Rev Pharmacol Toxicol       Date:  2002-01-10       Impact factor: 13.820

2.  Decreased Abeta secretion by cells expressing familial Alzheimer's disease-linked mutant presenilin 1.

Authors:  Masafumi Shimojo; Naruhiko Sahara; Miyuki Murayama; Hiroshi Ichinose; Akihiko Takashima
Journal:  Neurosci Res       Date:  2007-01-08       Impact factor: 3.304

Review 3.  Loss-of-function presenilin mutations in Alzheimer disease. Talking Point on the role of presenilin mutations in Alzheimer disease.

Authors:  Bart De Strooper
Journal:  EMBO Rep       Date:  2007-02       Impact factor: 8.807

4.  Age-dependent decline of neprilysin in Alzheimer's disease and normal brain: inverse correlation with A beta levels.

Authors:  E Hellström-Lindahl; R Ravid; A Nordberg
Journal:  Neurobiol Aging       Date:  2006-11-13       Impact factor: 4.673

Review 5.  Biogenesis and metabolism of Alzheimer's disease Abeta amyloid peptides.

Authors:  Geneviève Evin; Andreas Weidemann
Journal:  Peptides       Date:  2002-07       Impact factor: 3.750

Review 6.  A beta oligomers - a decade of discovery.

Authors:  Dominic M Walsh; Dennis J Selkoe
Journal:  J Neurochem       Date:  2007-02-05       Impact factor: 5.372

7.  Reduced levels of Abeta 40 and Abeta 42 in brains of smoking controls and Alzheimer's patients.

Authors:  E Hellström-Lindahl; M Mousavi; R Ravid; A Nordberg
Journal:  Neurobiol Dis       Date:  2004-03       Impact factor: 5.996

8.  Enhanced generation of intracellular Abeta42 amyloid peptide by mutation of presenilins PS1 and PS2.

Authors:  Kazuya Takeda; Wataru Araki; Takeshi Tabira
Journal:  Eur J Neurosci       Date:  2004-01       Impact factor: 3.386

Review 9.  Clinical, pathological, and biochemical spectrum of Alzheimer disease associated with PS-1 mutations.

Authors:  Alberto Lleó; Oksana Berezovska; John H Growdon; Bradley T Hyman
Journal:  Am J Geriatr Psychiatry       Date:  2004 Mar-Apr       Impact factor: 4.105

10.  Mutant presenilins specifically elevate the levels of the 42 residue beta-amyloid peptide in vivo: evidence for augmentation of a 42-specific gamma secretase.

Authors:  Joanna L Jankowsky; Daniel J Fadale; Jeffrey Anderson; Guilian M Xu; Victoria Gonzales; Nancy A Jenkins; Neal G Copeland; Michael K Lee; Linda H Younkin; Steven L Wagner; Steven G Younkin; David R Borchelt
Journal:  Hum Mol Genet       Date:  2003-11-25       Impact factor: 6.150

View more
  26 in total

Review 1.  Pathological implications of cell cycle re-entry in Alzheimer disease.

Authors:  David J Bonda; Hyun-pil Lee; Wataru Kudo; Xiongwei Zhu; Mark A Smith; Hyoung-gon Lee
Journal:  Expert Rev Mol Med       Date:  2010-06-29       Impact factor: 5.600

2.  Reduction of brain beta-amyloid (Abeta) by fluvastatin, a hydroxymethylglutaryl-CoA reductase inhibitor, through increase in degradation of amyloid precursor protein C-terminal fragments (APP-CTFs) and Abeta clearance.

Authors:  Mitsuru Shinohara; Naoyuki Sato; Hitomi Kurinami; Daisuke Takeuchi; Shuko Takeda; Munehisa Shimamura; Toshihide Yamashita; Yasuo Uchiyama; Hiromi Rakugi; Ryuichi Morishita
Journal:  J Biol Chem       Date:  2010-05-14       Impact factor: 5.157

Review 3.  The amyloid cascade hypothesis for Alzheimer's disease: an appraisal for the development of therapeutics.

Authors:  Eric Karran; Marc Mercken; Bart De Strooper
Journal:  Nat Rev Drug Discov       Date:  2011-08-19       Impact factor: 84.694

4.  Age and amyloid effects on human central nervous system amyloid-beta kinetics.

Authors:  Bruce W Patterson; Donald L Elbert; Kwasi G Mawuenyega; Tom Kasten; Vitaliy Ovod; Shengmei Ma; Chengjie Xiong; Robert Chott; Kevin Yarasheski; Wendy Sigurdson; Lily Zhang; Alison Goate; Tammie Benzinger; John C Morris; David Holtzman; Randall J Bateman
Journal:  Ann Neurol       Date:  2015-07-20       Impact factor: 10.422

5.  Upregulation of Aβ42 in the Brain and Bodily Fluids of Rhesus Monkeys with Aging.

Authors:  Qiao Zhao; Jing Lu; Zitong Yao; Shubo Wang; Liming Zhu; Ju Wang; Baian Chen
Journal:  J Mol Neurosci       Date:  2016-09-19       Impact factor: 3.444

6.  Interactions between Soluble Species of β-Amyloid and α-Synuclein Promote Oligomerization while Inhibiting Fibrillization.

Authors:  Jason Candreva; Edward Chau; Margaret E Rice; Jin Ryoun Kim
Journal:  Biochemistry       Date:  2019-12-30       Impact factor: 3.162

7.  Insulin differentially affects the distribution kinetics of amyloid beta 40 and 42 in plasma and brain.

Authors:  Suresh Kumar Swaminathan; Kristen M Ahlschwede; Vidur Sarma; Geoffry L Curran; Rajesh S Omtri; Teresa Decklever; Val J Lowe; Joseph F Poduslo; Karunya K Kandimalla
Journal:  J Cereb Blood Flow Metab       Date:  2017-06-01       Impact factor: 6.200

Review 8.  Review: cell cycle aberrations and neurodegeneration.

Authors:  D J Bonda; V P Bajić; B Spremo-Potparevic; G Casadesus; X Zhu; M A Smith; H-G Lee
Journal:  Neuropathol Appl Neurobiol       Date:  2010-01-06       Impact factor: 8.090

Review 9.  Understanding the roles of mutations in the amyloid precursor protein in Alzheimer disease.

Authors:  S Hunter; C Brayne
Journal:  Mol Psychiatry       Date:  2017-11-07       Impact factor: 15.992

10.  Delayed amyloid plaque deposition and behavioral deficits in outcrossed AβPP/PS1 mice.

Authors:  Brian A Couch; Meghan E Kerrisk; Adam C Kaufman; Haakon B Nygaard; Stephen M Strittmatter; Anthony J Koleske
Journal:  J Comp Neurol       Date:  2013-04-15       Impact factor: 3.215

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.